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Abstract.  Neutrophils roll on P-selectin expressed by 
activated platelets or endothelial cells under the shear 
stresses in the microcirculation. P-selectin glyco- 
protein ligand-1 (PSGL-1) is a  high affinity ligand for 
P-selectin on myeloid cells. However, it has not been 
demonstrated that PSGL-1  contributes to the rolling of 
neutrophils on P-selectin. We developed two IgG 
mAbs, PL1 and PL2, that appear to recognize protein- 
dependent epitopes on human PSGL-1. The mAbs 
bound to PSGL-1 on all leukocytes as well as on het- 
erologous cells transfected with PSGL-1 cDNA.  PL1, 
but not PL2, blocked binding of '25I-PSGL-1  to im- 
mobilized P-selectin, binding of fluid-phase P-selectin 
to myeloid and lymphoid leukocytes, adhesion of 
neutrophils to immobilized P-selectin under static 
conditions, and rolling of neutrophils on P-selectin- 
expressing CHO cells under a  range of shear stresses. 
PSGL-1  was localized to microvilli on neutrophils, a 
topography that may facilitate its adhesive function. 
These data indicate that (a) PSGL-1  accounts for the 
high affinity binding sites for P-selectin on leukocytes, 
and (b) PSGL-1  must interact with P-selectin in order 
for neutrophils to roll on P-selectin at physiological 
shear stresses. 
T 
H~  selectins  are  a  family of three  Ca2+-dependent 
membrane-bound lectins that initiate the rolling adhe- 
sion  of leukocytes to  platelets  or  endothelial cells 
under the shear forces found in the venular circulation (6, 25, 
33).  L-selectin, expressed on leukocytes, binds to consti- 
tutive or  inducible  ligands on  endothelial cells.  E-selec- 
tin, expressed by cytokine-activated endothelial cells, and 
P-selectin, expressed by thrombin-activated platelets and en- 
dothelial cells, bind to ligands on myeloid cells and subsets 
of lymphocytes. Although the selectins interact weakly with 
small sialylated, fucosylated oligosaccharides such as sialyl 
Lewis  x  (Galfll-4[Fuccd-3lGlcNAc)  (Le~)  ~ (17, 50),  they 
bind with higher affinity to glycans displayed on a limited 
number of glycoproteins (3, 5, 20, 26, 28, 29, 39, 52) or pro- 
teoglycans (41). A major unresolved issue is whether selec- 
tins must bind to these higher affinity, but less abundant, 
ligands in order for leukocytes to roll on the vessel wall un- 
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der physiological shear stresses (33, 51). An alternative hy- 
pothesis is that selectins need only bind to low affinity, but 
more abundant, glycans found on many different cell surface 
glycoproteins and glycolipids in order for leukocytes to roll. 
We have previously identified and characterized a sialo- 
mucin ligand for P-selectin that is expressed by human neu- 
trophils and the human promyelocytic HL-60 cell line (38, 
39, 40). It is a homodimer of disulfide-linked subunits with 
relative molecular masses  of ,~120,000.  The polypeptide 
component of this ligand is identical to that of P-selectin gly- 
coprotein ligand-1 (PSGL-1),  a molecule recently identified 
by expression cloning (38, 44).  The cDNA-derived amino 
acid sequence of PSGL-1 predicts a 402-residue type I mem- 
brane protein with a Ser/Thr/Pro-rich extracellular domain 
that contains three potential sites for addition of N-linked 
oligosaccharides as well as a single cysteine that might pro- 
mote dimerization (44). 
PSGL-1 functions as a ligand for P-selectin because it dis- 
plays specific oligosaccharide sequences recognized by the 
Ca2+-dependent  lectin  domain  of  P-selectin.  Binding  of 
P-selectin to PSGL-1 is Ca2+-dependent and is abolished by 
treatment of the ligand with sialidase (37, 38, 40).  PSGL-1 
expressed by human neutrophils displays up to three N-linked 
glycans and numerous sialylated O-linked glycans, including 
O-linked poly-N-acetyllactosamine which carry sialyl Le  ~ 
(38).  O-linked glycans are required for P-selectin recogni- 
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clustered nature of the O-linked oligosaccharides renders the 
polypeptide backbone of PSGL-1  sensitive to cleavage by 
O-sialoglycoprotein endopeptidase  (OSGE).  Treatment of 
intact HL-60 cells with this enzyme abolishes the high affin- 
ity binding sites for P-selectin and eliminates cell adhesion 
to immobilized P-selectin (40,  46, 49). 
These data suggest that PSGL-1 corresponds to function- 
ally important, high affinity binding sites for P-selectin on 
human myeloid cells and that it is a potentially important 
mediator  of neutrophil  rolling  on  P-selectin under  shear 
stresses. As for other glycoprotein ligands for selectins, how- 
ever, PSGL-1 on cell surfaces has not been demonstrated to 
participate in  selectin-mediated leukocyte adhesion under 
static or shear conditions. In this study we report the produc- 
tion and characterization of two mAbs raised against human 
neutrophil PSGL-1. Using these antibodies, we demonstrate 
that PSGL-1 represents the high affinity ligand for P-selectin 
on both myeloid and lymphoid leukocytes. We show that 
PSGL-1 mediates adhesion of neutrophils to P-selectin un- 
der  static  conditions as  well  as  rolling of neutrophils on 
P-selectin-expressing cells under the shear conditions found 
in the microcirculation. Our results establish that a selectin 
must form bonds with a specific glycoprotein ligand in order 
for neutrophils to roll under physiological shear stresses. 
Materials and Methods 
Antibodies 
The anti-human P-selectin mAbs S12 and GI (IgGt-r) were prepared and 
characterized as previously described (18, 34). Rabbit antiserum to a pep- 
tide  corresponding to  residues  42-56  (QATEYEYLDYDFLPE)  of the 
eDNA-derived amino acid sequence of PSGL-1  (44)  was produced and 
characterized as previously described (38). The anti-CD18 mAb IB4 (53) 
(IgG2A-r) waS a gift from Dr. Samuel Wright (The Rockefeller University, 
New York,  NY). Phycoerythrin-streptavidin (PE-streptavidin), FITC-Leu 
8  (anti-L-selectin), and  PE-Leu  15  (anti-CDllb)  were purchased from 
Becton-Dickinson Immunocytometry Systems (San Jose, CA).  Affinity- 
purified goat anti-mouse 3"-chain specific IgG and MOPC21 (IgGrr) were 
purchased from Cappel-Organon Technika (Durham, NC). 
Proteins 
Human platelet P-selectin and human neutrophil PSGL-1  were purified as 
previously described (35,  38).  A  recombinant soluble form of P-selectin 
(sPS, formerly called tPS) truncated after the ninth consensus repeat was 
immunoaffinity purified from conditioned medium of permanently trans- 
fected 293 cells and characterized as previously described (49). 
Monoclonal Antibody Production 
Baib/c mice were immunized i.p. with 20 #g of human neutrophil PSGL-I 
in Freund's complete adjuvant and boosted i.p.  60 d  later with 6  #g of 
PSGL-1  in Freund's incomplete adjuvant. After an additional 18 d, 4 d be- 
fore fusion, 6 ~g of PSGL-1 in PBS was administered i.p. Splenocytes were 
fused with P3-X63-Ag8-653 myeloma cells using polyethylene glycol 1500 
as previously described (16).  Hybridomas were screened based on their 
ability  to capture purified  t25I-labeled  PSGL-1  as previously described 
(38). Cells from positive wells were subcloned twice by limiting dilution. 
Antibodies were purified from ascites fluid by Protein G affinity chromatog- 
raphy.  Fab fragments were prepared using the ImmunoPure  ® Fab Prepara- 
tion Kit (Pierce Chemical Co., Rockford, IL). The purity of the mAb IgGs 
and Fah fragments was confirmed by silver staining of SDS-PAGE gels run 
under nonreducing and reducing conditions. The concentrations of mouse 
IgG or Fab fragments were estimated from 01328o using and Et~l cm of 14.0. 
Cell Isolation 
Human neutrophils were isolated from heparinized blood from consenting 
volunteers by dextran sedimentation, hypotonic lysis, and Ficoll-Paque den- 
sity gradient centrifugation as previously described (55).  Human mono- 
nuclear cells were isolated from heparinized whole blood by FieolI-Paque 
density gradient centrifugation. Quiescent platelets were isolated as previ- 
ously  described  (37).  Platelets  (10S/ml)  were  either  sham-  or  throm- 
bin-treated (0.1 U/mi bovine ct-thrombin) for 10 min at 22°C without stir- 
ring  in  HBSS/I%  HSA  containing  5  mM  EDTA.  HL-60  cells  were 
maintained in RPMI-1640/20%  FCS supplemented with 4  mM L-gluta- 
mine,  100 IU/ml penicillin, and  100/~g/ml streptomycin. 
Cloning of cDNA Encoding PSGL-1 
The PSGL-1  cDNA was amplified from human leukocyte QUICK-Clone" 
eDNA (Clontech Laboratories, Inc., Palo Alto, CA) using PCR. The oligo- 
nuelcotide pair (5'-TC~ GAG CTA AGC TTC TAG ACC ACC ATG CCT 
CTG CAA CTC CTC-3' and 5'-TGC GAG CGC TCG AGT CGA CTC ACT 
ACT TCA CAG AGA TGT GGT C-33 used in PCR was designed to in- 
troduce an XbaI site and a Kozak sequence preceding the initiation codon 
and to introduce a Sail site after the stop eodon. The eDNA was introduced 
as an XbaI-SalI fragment into Bluescript" II SK  +/- (Stratagene, La Jolla, 
CA).  The insert was excised with XbaI and KpnI and introduced as an 
XbaI-KpnI fragment into the mammalian expression vector pBK-EE pBK- 
EF, a generous gift from Dr. Kenji Fukudome (Oklahoma Medical Research 
Foundation, Oklahoma City, OK), was derived from pBK-CMV (Strata- 
gene, La Jolla, CA) by replacing the CMV promoter with the promoter for 
peptide chain elongation factor-lc~ (48). 
Transfections 
CHO cells and COS-'/cells, maintained in ot-MEM/10% FCS and DMEI 
10% FCS, respectively, were transfected at "~70% confluence in 100-mm 
culture  dishes  with  PSGL-I  eDNA  in  pBK-EF  using  Lipofectamine" 
(GIBCO BRL Life Technologies, Inc., Gaithersburg, MD) according to the 
instructions of the supplier. After 48 h transfeeted cells were harvested and 
washed once with HBSS before analysis. 
Protein lodination 
The mAb G1 and PSGL-1 were iodinated as previously described (38). The 
specific activity  of the  labeled mAb and  PSGL-1  ranged  from 0.5-1.0 
#Ci/mg protein and 14-30 ttCi/mg protein, respectively. Labeled proteins 
were routinely >95 % TCA precipitable. 
Site Density Determinations 
sPS  was  immobilized on Immulon I  microtiter plates.  The wells were 
blocked and saturating  concentrations of 125I-G1 (2.5  /tg/ml) in HBSS/ 
0.5% HSA were added to triplicate wells and incubated for 30 rain at 22°C. 
After washing the wells, bound antibody was eluted with 1 M NI-t,tOH and 
counted in a  3" counter.  Specific binding was defined as epm bound to 
selectin-coated wells minus epm bound to HSA-coated wells. For site densi- 
ties on P-selectin CHO cells, duplicate confluent monolayers were washed 
with ice cold HBSS and incubated with saturating concentrations of n25I- 
G1 (2.5 tzg/mi) in HBSS/0.5 % HSA for 30 rain at 4"C. The monolayers were 
washed four times with cold I-IBSS, lysed with 1 M NI-14OH, and counted 
in a 3" counter. Specific binding was defined as cpm bound to P-selectin 
CHO cells minus cpm bound to nontransfected CHO cells. Site densities 
were calculated assuming monovalent binding of antibody at saturation. 
Binding of usI-PSGL-1 to Immobilized P-Selectin 
Binding of 125I-PSGL-1 to immobilized P-selectin was performed as previ- 
ously described (38).  Certain assays were performed in the presence of 
anti-PSGL-1 mAbs. 
Adhesion of Neutrophils to P-Selectin under 
Static Conditions 
Adhesion of neutrophils to P-selectin immobilized on plastic was performed 
as previously described (18).  In certain experiments, cells were prein- 
cubated for 20 min with 10 ~g/ml of anti-PSGL-I mAbs before the adhesion 
assays. 
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P-Selectin under Flow Conditions 
CHO cell lines permanently expressing full-length P-selectin were gener- 
ated  as  previously described  (49).  A  dual-chamber,  parallel-plate  flow 
chamber was used to simulate the shear stresses in the microcirculation as 
previously described (21).  The flow chamber consists of a 35-mm culture 
dish covered with a confluent monolayer of CHO cells that is attached to 
a polycarbonate base via a silastic gasket which separates the two surfaces 
by ,0250 #m. The wall shear stresses were calculated using the momentum 
balance for a Newtonian fluid and controlled using a Harvard syringe pump. 
The interaction of neutrophils with the monolayer was monitored in real 
time using phase-contrast optics and was recorded on video tape using a 
computer imaging system via a charge-coupled camera. The dual Chamber 
design of the flow system allowed near simultaneous acquisition of data un- 
der two sets of experimental conditions on the same cell monolayer. Neutro- 
phils  resuspended at  106  cells/ml  in  HBSS/0.5%  HSA  were  perfused 
through the flow chamber at the desired shear stress. Rolling was allowed 
to equilibrate  for 4  rain before data acquisition.  Neutrophil  rolling was 
quantitated by digitizing image frames and determining the number of roll- 
ing leukocytes in two randomly selected 40×  fields. Preliminary experi- 
ments showed that rolling of neutrophils on P-selectin CHO cells was abol- 
ished by the inhibitory anti-P-selectin mAb G1, but not by the noninhibitory 
anti-P-selectin mAb S12,  indicating that rolling was P-selectin dependent. 
All experiments were performed at 22°C unless indicated otherwise. In cer- 
tain  experiments,  cells  were  preincubated  for  10  min  with  5  #g/ml  of 
anti-PSGL-I  mAbs. In other experiments, cells (106/ml)  were pretreated 
with either 2 gM cytochalasin D or DMSO diluent for 10 min at 37°C in 
HBSS/0.5%  HSA or with a  combination of 50 mM 2-deoxyglucose and 
0.06%  NaN3 for 60 rain at 22°C in HBSS/0.5%  HSA.  All inhibitors re- 
mained present during the adhesion assays. 
Flow Cytometry 
Binding of fluid-phase P-selectin to intact cells was assessed as previously 
described (36).  For indirect immunofluorescence staining, 106 cells were 
incubated with anti-PSGL-I  mAbs (50 #1,  10 ttg/ml). A concentration of 
10 gg/ml was found to be saturating for all the mAbs, including the Fab 
fragments of PL1. Bound antibody was detected with FITC-conjugated goat 
anti-mouse IgG/IgM.  Each incubation was for 30 min at 4°C in HBSS/ 
HSA/Ca, between which the cells were washed with HBSS/HSA/Ca. 
Iramunoelectron Microscopy 
Heparinized whole blood was mixed with 1/2 vol of 6% dextran in normal 
saline and after  1 h of sedimentation the leukocyte-rich plasma was col- 
lected  and  centrifuged at  300  g  for  5  min.  The  leukocyte  pellet  was 
resuspended and fixed with 2%  paraformaldehyde, 0.05% glutaraldehyde 
in 0.1 M  sodium phosphate buffer, pH 7.4, for 30 min at 22°C. The fixed 
cells were incubated with either a control IgGl mAb (X63) or a mixture of 
the anti-PSGL-1 mAbs PLI and PL2 (,o4 #g/ml) for 60 min. The cells were 
then incubated for 60 min with rabbit anti-mouse lgG/IgM/IgA (Zymed 
Inc., South San Francisco, CA) diluted 1:100, followed by protein A-gold 
5 nm (Laboratory of Cell Biology, Utrecht, The Netherlands) diluted 1:25. 
The  labeled  cells  were  refixed with  1.5%  glutaraldehyde,  1%  sucrose, 
0.067 M sodium cacodylate, pH 7.4, for 30 min and washed in sodium caco- 
dylate buffer. The cells were then postfixed in 1% OsO4 in veronal acetate 
buffer, stained with aqueous 1% uranyl acetate, dehydrated in ethanol, and 
embedded in epon (7). 
Results 
Anti-PSGL-1 mAbs Bind to Leukocytes 
To produce anti-PSGL-1 mAbs, mice were immunized with 
PSGL-1 isolated from human neutrophils.  Hybridomas se- 
creting  mAbs of interest  were identified  by immobilizing 
the mAbs on microtiter plates using a goat anti-mouse Ig and 
testing for their ability to capture radiochemically pure '25I- 
PSGL-1 from the fluid phase,  mAbs from two hybridomas 
were purified from ascites. The mAbs, designated PL1  and 
PL2,  were both of the IgG:r subclass.  Both mAbs bound 
similarly to PSGL-1 before or after digestion with sialidase, 
suggesting that they recognized protein-dependent epitopes. 
Binding to PSGL-1 was also equivalent in the presence or ab- 
sence of Ca  2÷. 
We used indirect immunofluorescence staining and flow 
cytometry to determine if these mAbs bound to intact leuko- 
cytes. Fig.  1 shows a representative analysis of sham-treated 
neutrophils (A), monocytes (B), and lymphocytes (C) stained 
with PL1,  PL2, or a control mouse IgGt (MOPC21).  Both 
anti-PSGL-1  mAbs  bound  to  the  surface  of neutrophils, 
monocytes,  lymphocytes,  and  HL-60 cells.  Neither  mAb 
bound to erythrocytes, quiescent platelets, or thrombin-acti- 
vated platelets (data not shown). 
PSGL-1  expressed  on  myeloid  cells  carries  numerous 
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Figure  1.  Binding of  anti- 
PSGL-1 mAbs to leukocytes. 
Human neutrophils and mono- 
nuclear cells were either sham 
treated (A-C) or treated with 
O-sialoglycoprotein endopep- 
tidase from Pasturella hemo- 
lytica (10  #1/5  ×  106  cells, 
1 h, 37°C) in HBSS/HSA/Ca 
(D-F). The cells were stained 
with  a  control  mouse  IgG~ 
mAb  (MOPC21),  PLI,  or 
PL2. Bound antibody was de- 
tected  with  FITC-conjugated 
goat  anti-mouse  IgG/IgM. 
For analysis of mononuclear 
cells,  events  were  acquired 
ungated and lymphocytes and 
monocytes were analyzed sep- 
arately based on their forward 
and  orthogonal  light  scatter 
properties.  The data are rep- 
resentative  of  two  indepen- 
dent experiments. 
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cleavage by O-sialoglycoprotein endopeptidase (40).  To de- 
termine if the anti-PSGL-1 mAb epitopes were susceptible 
to OSGE cleavage, intact cells were either sham- or enzyme- 
treated and analyzed by indirect immunofluorescence. Fig. 
1 shows a  representative analysis of OSGE-treated neutro- 
phils (D), monocytes (E), and lymphocytes (F) stained with 
PL1, PL2, or a control mouse IgGt (MOPC21).  Binding of 
PL1,  but  not  PL2,  was  abolished  by  enzyme  treatment. 
These data indicate that the PL1  epitope is within or distal 
to a serine/threonine-rich region of the PSGL-1 polypeptide 
that is cleaved by OSGE, whereas the epitope recognized by 
PL2 is more proximal to the membrane. 
Western Blot Analysis of Neutrophil Membrane 
Proteins  Using Anti-PSGL-1 Antibodies 
The  specificities  of the  anti-PSGL-1  antibodies  were  as- 
sessed by Western blotting of crude neutrophil membrane 
extracts that were fractionated on a  WGA affinity column 
(39).  Fig.  2 A  illustrates a silver-stained gel of WGA-bound 
proteins  fractionated  by  SDS-PAGE  under  reducing  con- 
ditions. PSGL-1 has an Mr of "~ 250,000 under nonreducing 
conditions  and  •120,000  under  reducing  conditions  and 
binds quantitatively to WGA as assessed by a  ~2q-P-selectin 
blotting assay (39, 44). Fig. 2 B shows that the anti-PSGL-1 
mAbs, PL1 and PL2, as well as an antiserum against a pep- 
tide corresponding to residues 42-56 of PSGL-1, each recog- 
nized a "~250-kD protein under nonreducing conditions and 
a  "~120-kD protein  under  reducing  conditions,  consistent 
with the expected electrophoretic mobility of PSGL-1. Both 
mAbs and the polyclonal antiserum also identified a minor 
protein with an Mr of '~160,000 under nonreducing condi- 
tions.  Neither the  mAbs nor the  anti-peptide serum iden- 
tiffed any protein in the WGA-unbound fraction (data not 
shown).  Because the  160-kD band was not apparent under 
reducing conditions, WGA-bound proteins were electropho- 
resed under nonreducing conditions and the region of the gel 
corresponding to the 160-kD band was excised. The gel slice 
was  then  electrophoresed  again  under  both  nonreducing 
and reducing conditions, transferred to Immobilon P mem- 
branes,  and probed with the anti-peptide serum.  Fig.  2  C 
shows that the anti-peptide serum recognized a 160-kD pro- 
tein under reducing as well as nonreducing conditions. When 
~2q-PSGL-1  was immunoprecipitated with the anti-peptide 
serum, the minor 160-kD protein (Fig. 2 D, arrow) as well 
as  the  250-kD  and  120-kD  proteins  were  identified.  The 
PSGL-1 used in the latter experiment was isolated by sequen- 
tial WGA and P-selectin affinity chromatography, suggesting 
that the 160-kD band is a sialylated glycoprotein that binds 
P-selectin in a  Ca2+-dependent fashion.  This property and 
its  reactivity  with  both  anti-PSGL-1  mAbs  and  the  anti- 
Figure 2. Analysis of the specificity of monoclonal and polyclonal antibodies to PSGL-1. (A) WGA-bound neutrophil membrane proteins 
(10/~g) were electrophoresed under reducing conditions in 7.5% SDS-polyacrylamide gels. Proteins were detected by silver staining. (B) 
WGA-bound proteins (10 #g) were electrophoresed under nonreducing (NR) and reducing (R) conditions in 7.5 % SDS-polyacrylamide gels, 
and then transferred to Immobilon P membranes. The membranes were blocked, and then probed with PLI, PL2, or an antiserum directed 
against a peptide corresponding to residues 42-56 of PSGL-1 (Anti-42-56). Bound antibody was detected by enhanced chemiluminescence 
using a HRP-conjugated anti-mouse or anti-rabbit antibody. (C) WGA-bound neutrophil membrane proteins (10/~g) were electrophoresed 
under nonreducing conditions in 7.5% SDS-polyacrylamide gels. The region of the gel corresponding to the  160-kD band was excised 
from the gel, split in half, and electrophoresed again under both nonreducing and reducing conditions. The proteins were then transferred 
to Immobilon P membranes and probed with the anti-42-56 serum. Bound antibody was detected by enhanced chemiluminescence using 
a HRP-conjugated anti-rabbit antibody. (D) Human neutrophil PSGL-I was purified by P-selectin affinity chromatography, radioiodinated, 
and immunoprecipitated with normal rabbit serum or with anti-42-56 serum (38). Immunoprecipitates were electrophoresed under non- 
reducing and reducing conditions in 7.5 % SDS-polyacrylamide gels, transferred to Immobilon P membranes, and then analyzed by autoradi- 
ography. DF, dye front. 
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lated to PSGL-1.  The 160-kD protein may be a monomeric 
isoform or glycoform of PSGL-1, because its apparent Mr is 
greater than that of the PSGL-1 monomer and is not affected 
by disulfide  bond reduction.  These  data  indicate  that  the 
mAbs and  the  anti-peptide  serum  are  highly  specific  for 
PSGL-1. 
Anti-PSGL-1 mAbs Bind to Recombinant PSGL-I 
To  determine  whether  the  mAbs  recognized recombinant 
PSGL-1, the PSGL-1 cDNA was amplified from leukocyte 
cDNA using PCR. DNA sequence analysis of our PSGL-1 
cDNA clone revealed a  30-bp insertion (5'-CC ACG GAG 
GCA CAG ACC ACT CAA CCA GTG C-3') between nucleo- 
tides 441  and 442 in the published cDNA sequence (44). 
This insertion encodes an additional in-frame decamer re- 
peat (ATEAQTTQPV) between amino acids 127 and 128 and 
changes Ala 12s to Pro. 
CHO  cells  and  COS-7  cells  were  mock transfected  or 
transfected with PSGL-1 cDNA and analyzed by indirect im- 
munofluorescence with  the  anti-PSGL-1  mAbs.  Transfec- 
tion of CHO cells and COS-7 cells with PSGL-1 cDNA con- 
ferred binding of both mAbs and the anti-peptide serum to 
the cells.  Fig.  3 shows a  representative analysis indicating 
that PL1 and PL2 bound to PSGL-l-transfected CHO cells, 
but not to mock-transfected CHO cells.  Treatment of the 
transfected cells with OSGE also prevented binding of PL1, 
but not PL2 (data not shown). These data further support the 
specificity of the anti-PSGL-1  monoclonal and polyclonal 
antibodies. 
PSGL  -1 Mediates High Affinity Binding of  P-Selectin 
to Leukocytes 
OSGE cleaves both PSGL-1  and the high affÉnity binding 
sites for P-selectin on myeloid cells, suggesting that PSGL-1 
might correspond to at least a  portion of the high affinity 
binding  sites  (40,  49).  To  address  this  possibility  more 
directly,  the anti-PSGL-1 mAbs were first screened for their 
ability  to  inhibit  binding  of  ~25I-PSGL-1 to  recombinant 
soluble P-selectin (sPS)  immobilized on plastic.  As previ- 
ously demonstrated (38), binding of PSGL-1 to P-selectin re- 
quired Ca  2÷ and was inhibited by G1,  a mAb to P-selectin 
that blocks binding of P-selectin to leukocytes, but not by 
S12, a mAb that does not affect leukocyte recognition (Fig. 
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Figure 3. Binding of anti-PSGL-I  mAbs to CHO cells transfected 
with PSGL-I cDNA. CHO cells were either mock transfected or 
transfected with PSGL-I eDNA in the expression vector pBK-EE 
The cells were stained with a control mouse IgG~ mAb (MOPC21), 
PLI, or PL2. Bound antibody was detected with FITC-conjugated 
goat anti-mouse IgG/IgM. The data are representative of two inde- 
pendent experiments. 
Figure 4.  Effect of mAbs to PSGL-1 or P-selectin on binding of 
~2sI-PSGL-1 to immobilized P-selectin. ~25I-PSGL-I  was incubated 
in the presence of the anti-PSGL-1 mAbs, PL1 or PL2, the anti-P- 
selectin mAbs, G1 or S12 (50 #1, 5/~g/ml), EDTA  (5 mM), or buffer 
for 1 h in microtiter wells in which either sPS (50/A,  10 ttg/ml) 
or HSA had been immobilized. The data represent the mean -t- SD 
of triplicate wells and are representative of  two independent experi- 
ments. 
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Figure  5.  Effect of mAbs of PSGL-1  on binding of fluid-phase P-selectin to leukocytes. Binding of platelet P-selectin (0.1 /zg/10  6 cells) 
to leukocytes was measured in the presence or absence of PLI or PL2 (1  /~g/l(P cells). For analysis of mononuclear cells, events were 
acquired ungated and lymphocytes and monocytes were analyzed separately based on their forward and orthogonai light scatter properties. 
The data are representative of two independent experiments. 
4). PL1, but not PL2, also inhibited binding of PSGL-1 to 
P-selectin in this assay (Fig. 4). We next used flow cytometry 
to test the effect of the anti-PSGL-1 mAbs on binding of 
fluid-phase P-selectin to leukocytes. Fig. 5 shows that PL1, 
but not PL2, blocked binding of P-selectin to neutrophils 
(A),  monocytes (B),  and  lymphocytes (C).  PLI,  but not 
PL2,  also  abolished binding of P-selectin to HL-60 cells 
(data not shown).  Control experiments demonstrated that 
binding of P-selectin to all cell types was abolished by OSGE 
treatment of the ceils and by incubation with mAb G1. These 
data  demonstrate  that  PSGL-1  accounts  for  all  the  high 
affinity binding sites for P-selectin on myeloid and lymphoid 
leukocytes. 
PSGL-1 Mediates Adhesion of Neutrophils  to 
P-Selectin under Static and Shear Conditions 
To examine the role of PSGL-I in cell adhesion under static 
conditions, we assayed neutrophil adhesion to P-selectin im- 
mobilized on plastic in the presence or absence of PL1 or 
PL2. Fig. 6 shows that PL1, but not PL2, potently inhibited 
neutrophil adhesion to immobilized P-selectin at site densi- 
ties  from 35  to  2300  sites/#m:.  PL1,  but  not PL2,  also 
abolished static adhesion of neutrophils to CHO ceils ex- 
pressing  P-selectin at  site densities from 85  to 250  sites/ 
/~m: (data not shown). 
To examine the function of PSGL-1 in rolling of neutro- 
phils  on  P-selectin,  a  dual-chamber,  parallel-plate  flow 
chamber was used to simulate the shear stresses in the micro- 
circulation. CHO cell clones expressing P-selectin at various 
site densities were grown to confluence on 35-mm culture 
dishes and inserted into the flow system. Neutrophils were 
preincubated with buffer or with saturating concentrations of 
anti-PSGL-1 mAbs for 10 min. Analysis of the neutrophils 
by flow cytometry before and after the experiments revealed 
no change in expression of L-selectin or CD1 lb, demonstrat- 
ing that the cells were not activated during the experimental 
manipulations. The neutrophils also remained rounded and 
refractile to light,  indicating they had not undergone acti- 
vation-induced polarization.  At a  shear stress of 1.5 dyn/ 
cm  2,  the number of neutrophils rolling on the CHO cells 
increased as a function of P-selectin site density (Fig. 7 A). 
PL1, but not PL2, abolished rolling of neutrophils on P-selec- 
tin CHO cells at sites densities ranging from 80 to 225 sites/ 
/~m  2 (Fig.  7 A).  Furthermore, PL1, but not PL2, blocked 
rolling of neutrophils on P-selectin CHO cells (212 sites/ 
#m0 at shear stresses ranging from 0.25 to 4 dyn/cm  2 (Fig. 
7 B). PL1, but not PL2, also abolished rolling of HL-60 cells 
on P-selectin CHO cells (data not shown). In control experi- 
ments,  preincubation of neutrophils with  IB4,  a  mAb to 
CD18 that binds to the cell surface, had no effect on neutro- 
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Figure 6. Effect of mAbs to PSGL-I on adhesion of neutrophils to 
immobilized P-selectin under static conditions.  Neutrophils (2  x 
105/well)  were  incubated  in the presence  or absence  of PL1  or 
PL2  (10/zg/ml) for 30 rain in microtiter wells in which sPS had 
been immobilized at increasing site densities.  After washing,  ad- 
herent neutrophils were quantitated with a myeloperoxidase assay. 
The data represent the mean +  SD of triplicate wells and are repre- 
sentative of two independent experiments. 
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Figure  7.  Effect of mAbs to PSGL-1 on rolling of neutrophils  on 
P-selectin CHO cells as a function of P-selectin site density and of 
shear stress.  (A) CHO cells  expressing  P-selectin  at  various  site 
densities were grown to confluence on 35-ram tissue culture dishes, 
and then inserted  into a parallel-plate  flow chamber.  Neutrophils 
(106/ml) in  HBSS/0.5%  HSA were preincubated  with  the  anti- 
PSGL-I mAbs, PL1, PL2 (5/~g/ml),  or buffer for 10 min, and then 
perfused through the chamber at  1.5  dyn/cm  2 for 4  min before 
data  acquisition.  (B)  Neutrophils  (l@/ml)  in HBSS/0.5%  HSA 
were preincubated  with PL1, PL2 (5 #g/ml), or buffer for 10 min 
and then perfused over P-selectin CHO cells (212 sites//~m  2) at the 
indicated  shear stress  for 4 rain before data acquisition.  The data 
points represent the mean +  range of the number of rolling neutro- 
phiis  in two randomly selected  40x  fields and are representative 
of two independent  experiments. 
phil rolling (data not shown).  Thus, PL1 eliminated rolling 
of neutrophils on P-selectin CHO cells at site densities which 
exceed those expressed by activated endothelium in vitro (19) 
and at a range of shear stresses found in postcapillary venules 
in vivo (30). 
Binding of bivalent antibodies may result in the redistribu- 
tion of cell surface antigens (23).  To exclude the possibility 
that bivalent PL1 IgG indirectly inhibited neutrophil rolling 
on P-selectin because it induced redistribution of PSGL-1 on 
the cell surface, we prepared monovalent Fab fragments of 
PL1 to use in the rolling experiments.  PL1 Fab fragments, 
like  PL1  IgG,  completely  inhibited  binding  of fluid-phase 
P-selectin to neutrophils.  Furthermore,  PL1 Fab fragments, 
like  bivalent  PL1  IgG,  blocked  rolling  of neutrophils  on 
P-selectin CHO cells  (data not shown). 
To  further  exclude  the  possibility  that the  anti-adhesive 
effect of PL1 IgG resulted from redistribution of PSGL-1, we 
pretreated  neutrophils  with  cytochalasin  D,  a  potent  and 
specific inhibitor  of actin polymerization (11).  Control ex- 
periments  showed that  cytochalasin D-treated  neutrophils 
failed to polarize and spread on albumin-coated plastic  in 
response to 0.1/~M FMLP, a response which requires actin 
polymerization  (45).  Fig.  8  shows  that both  DMSO-  and 
cytochalasin D-treated neutrophils rolled on P-selectin CHO 
cells, indicating that the cells do not require intact actin illa- 
ments to roll.  PL1 IgG, but not PL2 IgG, abolished roiling 
of both cytochalasin D treated and control neutrophils (Fig. 
8).  These data  further  indicate that PL1  IgG does  not in- 
directly block neutrophil rolling through cytoskeletally me- 
diated redistribution  of PSGL-1  on the cell  surface. 
Because neutrophils incubated with PL1 or PL2 IgG did 
not  change  shape,  it  seemed  unlikely  that  the  anti-adhe- 
sive effect of PL1 resulted from cell activation.  To confirm 
this hypothesis,  we examined the effects of PL1 or PL2 on 
rolling of neutrophils rendered metabolically inactive by pre- 
treatment with the metabolic inhibitors,  NaN3 and 2-deoxy- 
glucose, or by reducing the temperature to 4°C. Control ex- 
periments  showed that  neutrophils  treated  with  NaN3  and 
Figure 8. Inhibition of neutrophil  rolling on P-selectin by PLI is not 
due to redistribution  of PSGL-1 on the cell surface  or cell activa- 
tion.  CHO cells expressing  P-selectin (240 sites/#m  2) were grown 
to confluence on 35-mm tissue  culture dishes,  and then inserted 
into a parallel-plate  flow chamber.  Neutrophils  (106/ml) were in- 
cubated  with PL1, PL2 (5/zg/ml), or buffer for 10 min, and then 
perfused through the chamber at a shear stress  of 1.5 dyn/cm  2 at 
the indicated  temperature for 4 min before data acquisition.  The 
number of roiling  neutrophils  was quantitated.  In certain experi- 
ments,  neutrophils  (106/ml) were pretreated  with 2/~M cytochala- 
sin D (Cyto D) or diluent  (DMSO) in HBSS/0.5%  HSA for 10 min 
at 37°C, or with a mixture  of 50 mM 2-deoxyglucose (DOG) and 
0.06% NaN3 in HBSS/0.5%  HSA for 60 min at 22°C. 
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albumin-coated plastic in response to 0.1 #M FMLP. These 
responses  require  functional upregulation  of/32  integrins 
and active cellular metabolism (14, 32). Fig. 8 demonstrates 
that the treated neutrophils rolled on P-selectin CHO cells, 
Furthermore, PL1, but not PL2, blocked rolling of metaboli- 
cally  inactive neutrophils  as  well  as  control  neutrophils. 
Thus, PL1 does not indirectly inhibit rolling by activating the 
neutrophils. 
PSGL-1 Is Located on Microvilli of Neutrophils 
On neutrophils, L-selectin is localized on the tips of micro- 
villi (7, 15, 42), the points of initial contact between neutro- 
phils and endothelial cells during transendothelial migration 
in vitro (4). This surface topography is distinct from that of 
CDllb/CD18,  sialyl Le  x, and HLA Class I antigens, which 
are diffusely distributed on the cell body of the neutrophil 
(7, 15, 42). To investigate the surface distribution of PSGL-1, 
fixed neutrophils were analyzed by immunogold electron mi- 
croscopy with anti-PSGL-1 mAbs. Fig. 9 shows that the im- 
munogold label for PSGL-1 was localized to the tips of mi- 
crovilli. Control experiments performed with a non-binding 
IgG, mAb (X63) revealed no specific binding of gold to the 
plasma membrane. 
Discussion 
We produced two specific IgG mAbs, PL1 and PL2, that ap- 
pear  to  recognize protein-dependent epitopes  on  human 
PSGL-1. PL1, but not PL2, blocked binding of '2q-PSGL-1 
to immobilized P-selectin, binding of fluid-phase P-selectin 
to myeloid and lymphoid leukocytes, adhesion of neutrophils 
to P-selectin immobilized on plastic and to P-selectin CHO 
cells under static conditions, and rolling of neutrophils on 
CHO cells expressing P-selectin at a variety of site densities 
and under a range of physiologically relevant shear stresses. 
These data demonstrate that  PSGL-1  accounts for all  the 
high affinity binding sites for P-selectin on human leukocytes 
and that it mediates adhesion of neutrophils to P-selectin un- 
der both static and shear conditions. 
PSGL-1 contains many clustered, sialylated O-linked gly- 
cans that make it susceptible to cleavage with OSGE (40). 
Treatment of myeloid cells with OSGE eliminates the high 
affinity binding sites for P-selectin (49). We observed that 
digestion of both  myeloid and  lymphoid  leukocytes with 
OSGE removed an extracellular region of PSGL-1 that con- 
tained the PL1 epitope, but not a more proximal segment rec- 
ognized by PL2. Since PL1 completely blocked binding of 
fluid-phase P-selectin to leukocytes, PSGL-1, and not other 
OSGE-sensitive sialomucins  such as  leukosialin  (40,  47), 
Figure 9. Localization of PSGL-1 to microvilli on the neutrophil surface. Electron micrograph of a quiescent, fixed  human neutrophil in- 
cubated with a mixture of the anti-PSGL-1 mAbs, PL1 and PL2, followed by a bridge rabbit anti-mouse antibody, and then with protein 
A-gold 5 nm. Note that the majority of  the gold particles are concentrated on the tips of  microvilli of  varying length (arrows). Magnification: 
x51,000. Bar, 0.5/zm. 
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on the leukocyte surface. It is not known why PSGL-1 binds 
so well to P-selectin. Binding of P-selectin requires sialyla- 
tion (38,  39) and fucosylation (44)  of PSGL-1.  P-selectin 
binds to the O-linked glycans on PSGL-1, some of which dis- 
play poly-N-acetyllactosamine terminating in the sialylated 
and fucosylated tetrasaccharide, sialyl Le  x (38).  However, 
mere display of sialyl Le  ~ on glycoproteins is unlikely to 
confer high affinity binding unless its density is extremely 
high, because many other neutrophil surface glycoproteins 
carry sialyl Le  x, but do not bind well to P-selectin (1, 24, 
27, 31, 42). The O-linked glycans on PSGL-1 may have other 
functionally important modifications not yet characterized, 
and/or clusters of these glycans may create a unique binding 
"patch" for P-selectin (40). Protein-dependent recognition by 
the EGF domain of P-selectin has also been suggested as a 
mechanism for enhancing the affinity of binding to myeloid 
cells (22). It is striking that a relatively small Fab fragment 
of PL1  blocks binding of P-selectin to purified PSGL-1 as 
well as rolling of neutrophils on P-selectin. This observation 
suggests that PL1 masks a critical recognition site for P-selec- 
tin on PSGL-1 that is in close proximity to the PL1 epitope. 
Assuming that there is only one PL1 epitope on each subunit 
of PSGL-I, the binding site for P-selectin may reside in a rel- 
atively small  region of the molecule. This region may be 
located distal  to the membrane to facilitate contact with 
P-selectin on activated platelets or endothelial cells under 
shear conditions. 
We found that all lymphocytes expressed PSGL-1, hut only 
a minority of lymphocytes expressed a form of PSGL-1 that 
bound to P-selectin. Perhaps lymphocytes regulate the adhe- 
sive function of PSGL-1 by altering its glycosylation in re- 
sponse to antigenic challenge (12,  13,  36, 43). 
Transfected CHO cells expressing large quantities of sialyl 
Le  ~ adhere less well to immobilized P-selectin than do my- 
eloid cells (54). However, myeloid cells treated with OSGE 
do not adhere to P-selectin, even though the surface expres- 
sion of sialyl Le  ~ is unchanged (40).  These data indicate 
that mere surface expression of sialyl Le  x does not confer 
cell adhesion to P-selectin,  and  suggest that optimal  cell 
adhesion requires a higher affinity ligand(s) for P-selectin 
such as PSGL-1. PSGL-1 capable of binding P-selectin is a 
minor fraction of the total glycoproteins on the leukocyte 
cell surface (37, 49) or in myeloid cell extracts (40). Thus, 
it was possible that there were too few copies of PSGL-1 to 
support adhesion of leukocytes to cells expressing P-selec- 
tin. However, we found that the anti-PSGL-1 mAb PL1 com- 
pletely prevented adhesion of neutrophils  to immobilized 
P-selectin under static conditions, as well as rolling of neu- 
trophils on P-selectin CHO cells under shear stresses charac- 
teristic of postcapillary venules. PL1 did not indirectly in- 
hibit cell adhesion through cell signaling, because PLI also 
abolished rolling of neutrophils at 4°C and rolling of neutro- 
phils  treated  with  metabolic  inhibitors.  PL1  did  not  in- 
directly inhibit cell adhesion by inducing redistribution of 
PSGL-1,  because  it  abolished  rolling  of neutrophils  pre- 
treated with cytochalasin D, and monovalent Fab fragments 
of PL1 also blocked rolling. These data indicate that binding 
of PSGL-1 to P-selectin is a critical requirement for neutro- 
phil adhesion under static conditions, when there is ample 
time for receptor-ligand bonds  to  form, and under shear 
forces, when the requirements for bond formation are far 
more stringent. Thus, PSGL-1 serves an essential adhesive 
function even though it is only one of many glycoconjugates 
on the surface of the leukocyte. It is possible that PSGL-1 
functions cooperatively with  other ligands  for P-selectin. 
Without PSGL-1, however, such ligands cannot mediate neu- 
trophil adhesion even at high site densities of P-selectin in 
the absence of shear forces. 
We found that PSGL-1 was localized on the microvilli of 
neutrophils, the points of initial contact between neutrophils 
and endothelial cells in vitro (4). The clustering of PSGL-1 
on microvilli may favor rapid contact and subsequent bond 
formation with P-selectin on platelets and endothelial cells, 
particularly  under  shear  stress.  Activation of neutrophils 
does not affect the total surface expression of PSGL-1 as as- 
sessed by flow cytometry (Moore, K. L., unpublished obser- 
vation), consistent with earlier observations that activation 
does not change the number of high affinity binding sites for 
P-selectin (37). However, activation significantly diminishes 
the adhesion of neutrophils to P-selectin, even under static 
conditions (Lorant, D. E., R. P. McEver, T. M.  Mclntyre, 
K. L. Moore, S. M. Prescott, and G. A. Zimmerman, manu- 
script submitted for publication). This diminished adhesion 
is associated with a cytoskeletally mediated redistribution of 
the binding sites for P-selectin to the uropod of the neutro- 
phil. Further studies are needed to confirm that activation of 
neutrophils regulates the adhesive function of PSGL-1 by 
changing its distribution on the cell surface. 
mAbs to L-selectin partially inhibit adhesion of neutro- 
phils  to cell  surface P-selectin under rotating or laminar 
shear forces (10, 21, 42). It has been proposed that L-selectin 
is an important mediator of rolling of neutrophils on P-selec- 
tin because it carries sialyl Le  x and, like PSGL-1, is located 
on microvilli (7, 15, 42). However, P-selectin does not bind 
detectably to neutrophil L-selectin, indicating that any inter- 
action between the two molecules must be very weak (39). 
Furthermore, blockade of PSGL-1 with PL1 IgG or Fab frag- 
ments, under conditions that did not affect surface expression 
of L-selectin, completely inhibited rolling of neutrophils on 
P-selectin CHO cells. PL1 also eliminated rolling of HL-60 
cells, which lack L-selectin, on P-selectin. It remains possible 
that the colocalization of L-selectin and PSGL-1 on micro- 
villi of neutrophils allows them to cooperatively interact with 
P-selectin. However, our data indicate that L-selectin, in the 
absence of PSGL-1, does not mediate rolling of neutrophils 
on P-selectin, whereas PSGL-1, in the absence of L-selectin, 
does mediate rolling of HL-60 cells on P-selectin. 
On Western blots of neutrophil membrane extracts, the two 
anti-PSGL-1 mAbs, as well as the polyclonal antiserum to 
the PSGL-1 42-56 peptide, identified a minor protein with 
an apparent Mr of 'o160,000 under both nonreducing and 
reducing  conditions.  The anti-peptide  serum  also  immu- 
noprecipitated  a  minor  species  of similar  mobility  from 
J2q-PSGL-1 which was  isolated by P-selectin affinity chro- 
matography. Thus, the  160-kD protein is functionally and 
immunologically  related  to  PSGL-1.  The  electrophoretic 
properties of the protein suggest that it is a monomeric iso- 
form or glycoform of PSGL-1 with an Mr somewhat higher 
than that of the PSGL-1  monomer.  Lenter et al.  recently 
identified a glycoprotein ligand for P-selectin from HL-60 
cells  with  an  apparent  Mr  of 160,000  when  analyzed by 
SDS-PAGE under nonreducing conditions (28). This ligand 
had the unusual property that it could not be resolved by 
Moore et al.  PSGL-1 Mediates Rolling of Neutrophils on P-Selectin  669 SDS-PAGE  under  reducing  conditions  unless  it  was  first 
electrophoresed under nonreducing conditions, excised from 
the gel, and then electrophoresed under reducing conditions. 
The 160-kD glycoprotein ligand appeared to be distinct from 
PSGL-I, as it was reported not to bind to E-selectin, and to 
require N-linked glycans for recognition by P-selectin (28). 
Although the 160-kD ligand described by Lenter et al. has 
an electrophoretic mobility under reducing conditions that 
differs from that of the 160-kD PSGL-l-related species that 
we observed, it will be important to directly exclude the pos- 
sibility that it represents  the  160-kD  PSGL-l-related  spe- 
cies. Our studies indicate that the 160-kD glycoprotein de- 
scribed by Lenter et al. (1994), if it is distinct from PSGL-1, 
cannot mediate roiling of neutrophils  on P-selectin in the ab- 
sence of PSGL-1. 
Our results provide the first direct demonstration that the 
interaction of a selectin with a specific cell surface glycopro- 
tein is required for rolling of leukocytes under physiological 
shear forces. Similar types of experiments will be required 
to establish whether other high affinity glycoprotein ligands 
for selectins have  important functions in mediating leuko- 
cyte  adhesion,  particularly  under  shear  stresses.  In mice, 
L-selectin has been shown to bind to three different  sialo- 
mucin-like ligands, GIyCAM-1  (20, 26), CD34 (3, 20), and 
MAdCAM-1  (5). Because GIyCAM-1  is secreted from lym- 
phoid tissues into the circulation (9), it may serve to com- 
petitively  inhibit,  rather than promote,  L-selectin-dependent 
leukocyte adhesion.  Although CD34 is expressed on most 
endothelial cells (2), only CD34 from murine lymph nodes 
and from the inflamed pancreas  of diabetic mice has been 
demonstrated to bind L-selectin (2, 20), and a function for 
CD34 in mediating lymphocyte adhesion to endothelium has 
not  been  proven.  MAdCAM-1  purified  from  mesenteric 
lymph nodes supports rolling of L-selectin-transfected cells 
when it is coated in glass tubes (5). On an intact endothelial 
cell,  however,  the putative  mucin-like recognition site for 
L-selectin on MAdCAM-1  is predicted to reside relatively 
close to the membrane, where it may be masked by the gly- 
cocalyx such that it cannot form rapid bonds with L-selectin 
on flowing leukocytes (8). E-selectin binds to a 260-kD gly- 
coprotein on bovine 346 T cells (52) and to a 150-kD glyco- 
protein on murine and human myeloid cells (29), but a func- 
tion  for  either  molecule  in  cell  adhesion  has  not  been 
defined. 
In summary,  our data demonstrate that PSGL-1  accounts 
for all the high affinity  binding sites for P-selectin on leu- 
kocytes  and  is  required  for the  rolling  of neutrophils  on 
P-selectin in vitro. PSGLA also binds to E-selectin (28,  38, 
44),  but with significantly lower affinity  than to P-selectin 
(38).  The anti-PSGL-1  mAbs will help determine whether 
PSGL-1 contributes to the rolling of neutrophils on E-selec- 
tin, and whether PSGL-1  functions in the adhesion of other 
leukocytes to selectin-expressing cells. Further  studies are 
required to confirm the participation  of PSGL-1 in leukocyte 
rolling  in vivo.  Blockade  of PSGL-1  might  reduce  tissue 
damage in thrombotic and inflammatory disorders associ- 
ated with pathological leukocyte recruitment. 
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